IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q2 2021
Institutional positions in IMMUTEP Ltd as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +15 vs. Q1 2021
- Shares held
- 8.51M
- +3.95M (+86.6%) vs. Q1 2021
- Total value
- $32.9M
- +$18.9M (+135.2%) vs. Q1 2021
- New holders
- 17
- 4 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Barclays PLC | 183 | $1.00K | 0.00% | +183 | New |
| Pittenger & Anderson Inc | 500 | $2.00K | 0.00% | +500 | New |
| UBS Group AG | 1,338 | $5.00K | 0.00% | −4,530−77.2% | Reduced |
| Tower Research Capital LLC (TRC) | 1,218 | $5.00K | 0.00% | +1,218 | New |
| Captrust Financial Advisors | 1,700 | $7.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,174 | $8.00K | 0.00% | +2,174 | New |
| Evolution Wealth Advisors, LLC | 2,500 | $10.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 5,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11,517 | $45.0K | 0.00% | +11,517 | New |
| Geode Capital Management, LLC | 12,131 | $46.0K | 0.00% | +12,131 | New |
| Truist Financial Corp | 15,000 | $58.0K | 0.00% | +15,000 | New |
| HighTower Advisors, LLC | 16,000 | $62.0K | 0.00% | −26,000−61.9% | Reduced |
| Jump Financial, LLC | 24,100 | $93.0K | 0.01% | +24,100 | New |
| Goldman Sachs Group Inc | 36,282 | $140.0K | 0.00% | +36,282 | New |
| Private Wealth Advisors | 39,068 | $151.0K | 0.05% | +39,068 | New |
| Virtu Financial LLC | 48,467 | $188.0K | 0.02% | −50,743−51.1% | Reduced |
| Citadel Advisors LLC | 48,857 | $189.0K | 0.00% | +48,857 | New |
| Alps Advisors Inc | 51,000 | $197.0K | 0.00% | +51,000 | New |
| Saturna Capital CORP | 89,500 | $346.0K | 0.01% | +89,500 | New |
| Renaissance Technologies LLC | 90,819 | $351.0K | 0.00% | −136,381−60.0% | Reduced |
| Marshall Wace, LLP | 165,768 | $642.0K | 0.00% | +165,768 | New |
| Verition Fund Management LLC | 655,102 | $2.54M | 0.04% | +130,102+24.8% | Added |
| Oracle Investment Management Inc | 1,000,000 | $3.87M | 0.54% | +1,000,000 | New |
| Artal Group S.A. | 1,000,000 | $3.87M | 0.09% | +1,000,000 | New |
| Morgan Stanley | 1,291,246 | $5.00M | 0.00% | +213,599+19.8% | Added |
| Millennium Management LLC | 1,403,441 | $5.43M | 0.01% | +1,191,972+563.7% | Added |
| Boxer Capital, LLC | 2,500,000 | $9.68M | 0.34% | +500,000+25.0% | Added |
| Eversept Partners, LP | 0 | $0 | 0.00% | −249,895−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −115,000−100.0% | Sold out |